SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 428,40
arrow_upward
+1,42%(+6,00) 1D
9 Okt., 17:29:43 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 427,60
High
SEKÂ 431,60
Low
SEKÂ 426,60
Mkt. cap
153,21Â mjd
Avg. vol.
268,70Â k
Volume
179,02Â k
P/E ratio
114,42
52-wk high
SEKÂ 487,00
52-wk low
SEKÂ 293,60
EPS
SEKÂ 3,74
Shares outstanding
357,64Â m
No. of employees
2Â k
Open
SEKÂ 427,60
High
SEKÂ 431,60
Low
SEKÂ 426,60
Mkt. cap
153,21Â mjd
Avg. vol.
268,70Â k
Volume
179,02Â k
P/E ratio
114,42
52-wk high
SEKÂ 487,00
52-wk low
SEKÂ 293,60
EPS
SEKÂ 3,74
Shares outstanding
357,64Â m
No. of employees
2Â k
News stories
From web sources and news partners
The Manila Times
·
15 minute gelede
Terminal1, the operating system built for public companies, announced today that U.S Gold Corp (NASDAQ:USAU) has joined the Terminal1 platform
TradingView
·
37 minute gelede
Wall St headed for weekly gains as earnings season nears
ChartMill
·
25 minute gelede
Which S&P500 stocks have an unusual volume on Friday?
Nasdaq
·
4 uur gelede
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)